| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 6.294 | 11.820 | 4.419 | 449 | 0 | 0 | 0 | 0 | 271 | - |
| Gross Profit/Loss - EUR | -6.294 | -11.820 | -4.381 | -449 | 0 | 0 | 0 | 0 | -271 | - |
| Net Profit/Loss - EUR | -6.294 | -11.820 | -4.381 | -449 | 0 | 0 | 0 | 0 | -271 | - |
| Employees | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Biopinvents S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 55.688 | 58.525 | 53.754 | 52.767 | 51.745 | 50.765 | 49.639 | 49.793 | 41.761 | - |
| Inventories | 0 | 10.222 | 10.088 | 9.902 | 9.711 | 9.527 | 9.315 | 9.344 | 1.705 | - |
| Receivables | 60 | 1.017 | 1.166 | 1.145 | 1.123 | 1.101 | 1.077 | 1.080 | 1.077 | - |
| Cash | 55.628 | 47.286 | 42.500 | 41.720 | 40.912 | 40.137 | 39.246 | 39.368 | 38.978 | - |
| Shareholders Funds | 54.700 | 42.322 | 37.224 | 36.092 | 35.393 | 34.722 | 33.952 | 34.058 | 33.684 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 989 | 16.204 | 16.529 | 16.675 | 16.352 | 16.042 | 15.686 | 15.735 | 8.077 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biopinvents S.r.l.